Dr Herbst on Adjuvant Osimertinib in EGFR-mutant NSCLC | OncLive
Dr Herbst on Adjuvant Osimertinib in EGFR-mutant NSCLC | OncLive
Jun 4, 2023
onclive.com
Ways to Manage Toxicities Related to Osimertinib for Lung Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Ways to Manage Toxicities Related to Osimertinib for Lung Cancer | T…
Jun 14, 2023
targetedonc.com
Dr. Low on Osimertinib Versus Dacomitinib in EGFR-Mutant NSCLC | OncLive
Dr. Low on Osimertinib Versus Dacomitinib in EGFR-Mutant NSC…
Oct 30, 2019
onclive.com
Treatment Approaches After Adjuvant Osimertinib | OncLive
Treatment Approaches After Adjuvant Osimertinib | OncLive
Jun 24, 2021
onclive.com
Osimertinib, the Standard for EGFR NSCLC | OncLive
Osimertinib, the Standard for EGFR NSCLC | OncLive
Feb 26, 2019
onclive.com
Dr. Oxnard on the Role of Osimertinib in the TATTON Trial for Lung Cancer | OncLive
Dr. Oxnard on the Role of Osimertinib in the TATTON Trial fo…
4 weeks ago
onclive.com
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mutant Advanced Non-Small Cell Lung Cancer (NSCLC) With Biomarkers of High-Risk Disease: A Secondary Analysis From the Phase 3 MARIPOSA Study | OncLive
Amivantamab Plus Lazertinib vs Osimertinib in First-Line EGFR-Mu…
Jun 19, 2024
onclive.com
Dr. Kris on Predicting Benefit With Osimertinib in EGFR NSCLC | Onc…
Jun 13, 2019
onclive.com
Dr. Padda on Selecting a Therapy Following Osimertinib Resistance …
Jul 30, 2021
onclive.com
Dr Le on the Efficacy of Osimertinib Plus Ramucirumab in EGFR-Muta…
Oct 28, 2023
onclive.com
Osimertinib Monotherapy vs. Combination Therapy: Patient Sel…
Jul 16, 2024
onclive.com
LAURA: Osimertinib after Definitive CRT in Unresectable Stage III NSC…
Jun 11, 2024
targetedonc.com
Data From FLAURA2: Osimertinib With or Without Chemotherapy in …
1 week ago
targetedonc.com
12:18
Osimertinib (osi) After Definitive Chemoradiotherapy (CRT) in Patie…
Jun 24, 2024
onclive.com
Early Use of Osimertinib with Chemotherapy Significantly Boost…
5 months ago
archyde.com
Dr Jänne on the FLAURA2 and MARIPOSA Trials of Single-Agent …
Aug 9, 2023
onclive.com
1:14
Predictive Biomarkers for Treatment With Amivantamab Plus Lazertini…
Apr 29, 2024
onclive.com
21:25
Amivantamab Plus Chemotherapy (With or Without Lazertinib) vs Ch…
Oct 31, 2023
onclive.com
Why a Targeted Therapy Is Better Than Immunotherapy for Some Pa…
Jan 31, 2024
yale.edu
LAURA Trial (NEJM/ASCO 2024): Osimertinib After Chemoradiother…
7 months ago
YouTubeCancer Research and Statistic Foundation
Phase III MARIPOSA: amivantamab + lazertinib vs osimertinib in EGF…
1.9K viewsOct 22, 2023
YouTubeVJOncology
How to pronounce osimertinib
1.1K viewsAug 21, 2021
YouTubeBiomedical Pronunciation Guide
1:53
Resistance to Osimertinib in EGFR-Mutated NSCLC
490 viewsJun 4, 2019
YouTubeOncLive
0:48
LAURA Trial - Osimertinib as Consolidation in non-small cell lu…
485 viewsJun 16, 2024
YouTubeOncBrothers: Practice-Changing Cancer Discus…
SAILING THE WORLD WITH ONLY 6 MONTHS TO LIVE
1.9M viewsAug 16, 2020
YouTubeGone with the Wynns
How to Pronounce Osimertinib
4.6K viewsMar 13, 2023
YouTubeJulien Miquel
3:39
Staging of Lung Cancer
219.8K viewsNov 20, 2017
YouTubeYou and Lung Cancer
2:21
Osimertinib in Advanced Non–Small-Cell Lung Cancer
46.4K viewsFeb 16, 2017
YouTubeNEJM Group
0:52
Selecting EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Lung …
532 viewsMar 20, 2020
YouTubeTargeted Oncology
6:57
EGFR Exon 20 Mutations in Non–Small Cell Lung Cancer
2.4K viewsAug 28, 2020
YouTubeOncLive
See more videos
Static thumbnail place holder